Therapeutic Outcomes of High Dose-Dexamethasone versus Prednisolone + Azathioprine, Rituximab, Eltrombopag, and Romiplostim Strategies in Persistent, Chronic, Refractory, and Relapsed Immune Thrombocytopenia Patients.
Pharmaceuticals (Basel)
; 16(9)2023 Aug 29.
Article
in En
| MEDLINE
| ID: mdl-37765023
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Pharmaceuticals (Basel)
Year:
2023
Document type:
Article
Affiliation country:
Egypt
Country of publication:
Switzerland